Autopsy report · NCT06570161

Assessment of Fit of Novel N95 Style Transparent Face Masks

“funding terminated”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Brigham and Women's Hospital

Sponsor type

University, hospital or other

Conditions

Respiratory Disease; Infection, Coronavirus; Respiratory Tract Infections

Interventions

SEEUS95 Transparent mask; CrystalGuard Mask; N95 face mask

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
  “Funding was terminated” (97% match in meaning)
• Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
  “Funding terminated by funding source.” (91% match in meaning)
• Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
  “Souces of funding have been terminated” (89% match in meaning)
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
  “Terminated due to insufficient funding” (88% match in meaning)
• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
  “Terminated due to loss of funding” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.